Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice
- PMID: 14688097
- PMCID: VSports在线直播 - PMC343982
- DOI: 10.1128/IAI.72.1.196-208.2004
Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice
Abstract
Peptide mimotopes of capsular polysaccharides have been proposed as antigens for vaccines against encapsulated pathogens. In this study, we determined the antibody response to and efficacy of P13, a peptide mimetic of the Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan (GXM), in mice that produce human antibodies. P13 was conjugated to tetanus toxoid (TT) or diphtheria toxoid (DT) and administered subcutaneously in Alhydrogel with or without CpG to mice transgenic for human immunoglobulin loci (XenoMouse mice) and expressing either immunoglobulin G2 (IgG2) (G2 mice) or IgG4 (G4 mice). Mice were vaccinated and revaccinated two or three times. The serum antibody responses of the mice to GXM and P13 and antibody idiotype expression were analyzed by an enzyme-linked immunosorbent assay. The results showed that both P13-TT and P13-DT were antigenic, inducing a mimetic response to P13 in both G2 and G4 mice, and immunogenic, inducing a mimotope response including VH3 (idiotype)-positive antibodies to GXM in G2 but not G4 mice. CpG led to higher titers of IgG to P13 and GXM in P13-TT-vaccinated G2 mice VSports手机版. C. neoformans challenge of P13-protein conjugate-vaccinated and control G2 mice induced anamnestic IgG- and VH3-positive responses to GXM and was associated with a significantly decreased risk of death and a prolongation of survival in P13-DT-vaccinated mice compared to phosphate-buffered saline-treated or protein carrier-vaccinated mice. These findings reveal that P13 elicited a human antibody response with VH3 expression in human immunoglobulin transgenic mice that has been observed for human antibodies to GXM and support the concept that peptide mimotope-based vaccines may hold promise for the treatment of C. neoformans infections. .
Figures (VSports注册入口)






References
-
- Aalberse, R. C., and J. Schuurman. 2002. IgG4 breaking the rules. Immunology 105:9-19. - "VSports在线直播" PMC - PubMed
-
- Aalberse, R. C., J. Schuurman, and R. Van Ree. 1999. The apparent monovalency of human IgG4 is due to bispecificity. Int. Arch. Allergy Immunol. 118:187-189. - PubMed
-
- Abadi, J., J. Friedman, R. Jefferis, R. A. Mageed, and L. Pirofski. 1998. Human antibodies elicited by a pneumococcal vaccine express idiotypic determinants indicative of VH3 gene segment usage. J. Infect. Dis. 178:707-716. - PubMed (VSports在线直播)
-
- Abadi, J., and L. Pirofski. 1999. Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without HIV infection. J. Infect. Dis. 180:915-919. - V体育平台登录 - PubMed
-
- Aberg, J. A., R. W. Price, D. M. Heeren, and B. Bredt. 2002. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy. J. Infect. Dis. 185:1179-1182. - PubMed
Publication types
- "V体育2025版" Actions
MeSH terms
- Actions (V体育ios版)
- "VSports" Actions
- "VSports app下载" Actions
- Actions (V体育平台登录)
- V体育官网 - Actions
- V体育官网 - Actions
- Actions (VSports手机版)
- V体育官网 - Actions
- "VSports最新版本" Actions
- VSports app下载 - Actions
- "VSports" Actions
- Actions (VSports app下载)
Substances
- Actions (V体育官网入口)
- V体育平台登录 - Actions
- "VSports" Actions
- Actions (VSports app下载)
- VSports - Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources